Imprint of unconventional T-cell response in acute hepatitis C persists despite successful early antiviral treatment.
Du Y, Khera T, Strunz B, Deterding K, Todt D, Woller N, Engelskircher SA, Hardtke S, Port K, Ponzetta A, Steinmann E, Cornberg M, Hengst J, Björkström NK, Wedemeyer H; HepNet Acute HCV Ⅳ Study Group.
Du Y, et al. Among authors: khera t.
Eur J Immunol. 2022 Mar;52(3):472-483. doi: 10.1002/eji.202149457. Epub 2021 Dec 13.
Eur J Immunol. 2022.
PMID: 34843107
Free article.